Author:
Chang Kwok Chiu,Leung Chi Chiu
Reference115 articles.
1. Abel, L., Cua, V. V., Oberti, J., Lap, V. D., Due, L. K., Grosset, J., et al. (1990). Leprosy and BCG in southern Vietnam. Lancet, 335(8704), 1536.
2. Abu-Raddad, L. J., Sabatelli, L., Achterberg, J. T., Sugimoto, J. D., Lonjini, I. M., Jr., Dye, C., et al. (2009). Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proceedings of the National Academy of Sciences U.S.A., 106, 13980–13985.
3. Arbeláez, M. P., Nelson, K. E., & Muñoz, A. (2000). BCG vaccine effectiveness in preventing tuberculosis and its interaction with human immunodeficiency virus infection. International Journal of Epidemiology, 29, 1085–1091.
4. Aronson, J. D. (1948a). BCG vaccination among American Indians. American Review of Tuberculosis, 57, 96–99.
5. Aronson, J. D. (1948b). Protective vaccination against tuberculosis with special reference to BCG vaccination. American Review of Tuberculosis, 58, 255–281.